Protecting Patients from Progression
The first molecular prognostic test for cervical dysplasia may help determine the need for treatment
Michael Schubert | | Quick Read
For patients who receive a diagnosis of cervical dysplasia, the future can be uncertain. Many cases resolve without treatment, but some progress to cancer. Deciding whether or not to undergo surgery – which carries risks to the patient’s sexual and psychological wellbeing and to potential future pregnancies – is challenging and, until now, there has been no way to predict which cases are most likely to progress.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.